Lipocine Inc (LPCN): WHY DO YOU LIE?

Reply Private New

Replies (1) Next 10 Prev Next

Rapture2020

Send PM Follow Ignore

Followers	36
Posts	5775
Boards Moderated	0
Alias Born	02/20/2015

Rapture2020

Re: gi197845 post# 554

Saturday, 06/13/2020 7:00:54 PM

Saturday, June 13, 2020 7:00:54 PM

WHY DO YOU LIE?

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent LPCN News

Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:35:09 PM
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024 • PR Newswire (US) • 11/07/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 11:09:10 AM
Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 09:37:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 01:35:23 PM
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea • PR Newswire (US) • 10/31/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:05:33 PM
Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results • PR Newswire (US) • 10/10/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 10:04:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 01:30:11 PM
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries • PR Newswire (US) • 10/08/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 01:35:10 PM
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 • PR Newswire (US) • 10/02/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:35:22 PM
Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference • PR Newswire (US) • 09/30/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:35:10 PM
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek® • PR Newswire (US) • 09/05/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 03:23:16 PM
Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/27/2024 12:00:00 PM
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024 • PR Newswire (US) • 08/08/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:20:27 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:19:03 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:05:52 PM
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study • PR Newswire (US) • 06/25/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 01:00:30 PM

More LPCN News

InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover